Scott Boyken

Scott Boyken has a diverse work experience in the field of biotechnology and protein engineering. Scott co-founded Outpace Bio in 2020, where they serve as the Chief Technology Officer. At Outpace Bio, Scott combines protein design, synthetic biology, and cell engineering to develop advanced cell and gene therapies.

Prior to their role at Outpace Bio, Scott co-founded Lyell Immunopharma in 2019, where they served as the Co-Director of Protein & Cell Engineering until 2020. During their time at Lyell Immunopharma, they played a crucial role in the development and advancement of protein and cell engineering technologies.

Before their entrepreneurial ventures, Scott worked as a Postdoctoral Fellow at the University of Washington from 2013 to 2018. In this role, they focused on conducting research in the field of biotechnology.

Overall, Scott Boyken's work experience showcases their expertise in biotechnology, protein design, and cell engineering, and their commitment to developing innovative therapies and technologies in the field.

Scott Boyken completed their Bachelor of Arts degree in Computer Science and Biology double major from Luther College, where they attended from 2003 to 2007. Scott later pursued their Doctor of Philosophy degree in Computational Biology from Iowa State University, completing it from 2007 to 2013.